Mépolizumab chez les patients avec ≥ 3 exacerbations et...

Revue Française d'Allergologie 2018 / 04 Vol. 58; Iss. 3

Mépolizumab chez les patients avec ≥ 3 exacerbations et un taux d’éosinophiles count ≥ 300 cellules/μL

Yancey, S., Gruber, A., Albers, F., Bradford, E., Keene, O., Price, R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
58
Language:
french
Journal:
Revue Française d'Allergologie
DOI:
10.1016/j.reval.2018.02.176
Date:
April, 2018
File:
PDF, 184 KB
french, 2018
Conversion to is in progress
Conversion to is failed